Skip to search formSkip to main contentSkip to account menu

ponalrestat

Known as: 3-(4-Bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-1-phthalazineacetic Acid, 3-(4-bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-3H-phthalazin-1-ylacetic acid 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Enzyme InhibitorsHypoglycemic AgentsPhthalazines

Narrower (2)

ICI 128436Statil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
25th Annual Meeting of the European Association for the Study of Diabetes Lisbon, Portugal, 20–23 September 1989
1. Effect of diabetic autonomic neuropathy on pregnancy outcome K. E. J. Airaksinen, M. Anttila, M. Linnaluoto, P. Jouppila, J. T… 
1994
1994
DER EINFLUSS DES ALDOSE-REDUKTASE-INHIBITORS PONALRESTAT AUF DIE DIABETISCHE POLYNEUROPATHIE : EINE EINJAHRIGE DOPPELBLINDSTUDIE